Rocket


News + Filings
Transactions
Holdings



Trieu Vuong

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/29/2023Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock425k$0.02$8.9k 06/28/2023
06/28/2023Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock75k$0.03$2k 06/28/2023
06/14/2023Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock400k$0.03$13k 06/14/2023
05/26/2023Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock126.9k$0.03$4.3k 05/26/2023
05/02/2023Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock100k$0.05$4.5k 05/02/2023
12/06/2022Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock120k$0.05$6k 12/06/2022
11/22/2022Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock70k$0.08$5.6k 11/22/2022
09/26/2022Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock20k$0.07$1.4k 09/26/2022
09/03/2021Oncotelic Therapeutics, Inc.MATNGrantStock Options225k$0.14$31.3k 09/03/2021
07/08/2021Oncotelic Therapeutics, Inc.MATNGrantCommon Stock259.3k$0.00$0 03/31/2021
07/08/2021Oncotelic Therapeutics, Inc.MATNGrantStock Options514k$0.16$83.6k 03/31/2021
03/31/2021Oncotelic Therapeutics, Inc.MATNConversionCommon Stock5.7M$0.00$0By Spouse03/31/2021
03/31/2021Oncotelic Therapeutics, Inc.MATNConversionSeries A Convertible Preferred Stock74.5k$0.00$0 03/31/2021
03/31/2021Oncotelic Therapeutics, Inc.MATNConversionSeries A Convertible Preferred Stock13.8k$0.00$0By Autotelic, Inc.03/31/2021
03/31/2021Oncotelic Therapeutics, Inc.MATNConversionSeries A Convertible Preferred Stock5.7k$0.00$0By Spouse03/31/2021
03/31/2021Oncotelic Therapeutics, Inc.MATNConversionCommon Stock74.5M$0.00$0 03/31/2021
03/31/2021Oncotelic Therapeutics, Inc.MATNConversionCommon Stock13.8M$0.00$0By Autotelic, Inc.03/31/2021
11/19/2020Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock50.5k$0.19$9.6k 11/19/2020
03/26/2020Oncotelic Therapeutics, Inc.MATNPurchaseCommon Stock3k$0.12$360 03/26/2020
04/16/2018Adhera Therapeutics, Inc.ATRXConversion5% Demand Line of Credit0$5,000.00$0 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversionSeries E Convertible Preferred Stock19$0.50$9.5By Autotelic Inc.04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversionWarrants to Purchase Common Stock142.5k$0.55$78.4kBy Autotelic Inc.04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversion5% Demand Line of Credit0$5,000.00$0By Autotelic Inc.04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXPurchaseSeries E Convertible Preferred Stock162.59$0.50$81.3By Autotelic Inc.04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXPurchaseWarrants to Purchase Common Stock2.6M$0.55$1.4MBy Autotelic Inc.04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXGrantSeries E Convertible Preferred Stock2.25$0.50$1.1 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXGrantWarrants to Purchase Common Stock16.9k$0.55$9.3k 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversionSeries E Convertible Preferred Stock34.51$0.50$17.3 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversionWarrants to Purchase Common Stock258.8k$0.55$142.4k 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversion5% Convertible Promissory Note0$5,000.00$0 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversionSeries E Convertible Preferred Stock114.63$0.50$57.3 04/16/2018
04/16/2018Adhera Therapeutics, Inc.ATRXConversionWarrants to Purchase Common Stock859.7k$0.55$472.8k 04/16/2018
01/03/2018Adhera Therapeutics, Inc.ATRXGrantOptions to purchase common stock3.8k$1.56$5.9k 01/03/2018
06/30/2017Adhera Therapeutics, Inc.ATRXGrant5% Convertible Promissory Note0$0.35$0 06/30/2017
06/08/2017Adhera Therapeutics, Inc.ATRXPurchaseCommon Stock20k$0.39$7.8k 06/07/2017
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy